EUVIMEDEUVIMED entdecken
Crossref

Associations of the Serum KL-6 with Severity and Prognosis in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Yu Wang, Jun Fei, Juan Xu, Zhen-Yu Cheng, Yi-Cheng Ma, Ju-Hong Wu, Jin Yang, Hui Zhao, Lin Fu

Lung · 2024-06 · 202 (3) · 245-255

DOI: 10.1007/s00408-024-00702-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lung, online erschienen am 14.05.2024. Verfasst von Yu Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Mucin-1, Severity of Illness Index, Biomarkers. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, the Anhui Provincial Natural Science Foundation, the National Natural Science Foundation Incubation Program of the Second Affiliated Hospital of Anhui Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveMucin-1Severity of Illness IndexBiomarkersC-Reactive ProteinDisease ProgressionInterleukin-6HumansMaleFemaleAgedPrognosisProspective StudiesMiddle AgedCase-Control StudiesUric AcidL-Lactate DehydrogenaseLeukocyte CountAged, 80 and over

Stichwörter der Autor:innen

Acute exacerbation of chronic obstructive pulmonary disease (AECOPD)KL-6PrognosisSeverity

Substanzen

Mucin-1MUC1 protein, humanBiomarkersC-Reactive ProteinInterleukin-6Uric AcidL-Lactate Dehydrogenase

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.
  • Institute of Respiratory Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.
  • Department of Thoracic Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China.
  • Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China. yangqj1015@foxmail.com.
  • Institute of Respiratory Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China. yangqj1015@foxmail.com.
  • Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China. zhaohuichenxi@126.com.

Förderung

  • the National Natural Science Foundation of China
  • the Anhui Provincial Natural Science Foundation
  • the National Natural Science Foundation Incubation Program of the Second Affiliated Hospital of Anhui Medical University
  • the Scientific Research of Health Commission in Anhui Province
  • the University Natural Science Research Project of Anhui Province

Zitieren

APA

Wang, Y., Fei, J., Xu, J., Cheng, Z. Y., Ma, Y. C., Wu, J. H., Yang, J., Zhao, H., & Fu, L. (2024). Associations of the Serum KL-6 with Severity and Prognosis in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Lung, 202(3), 245-255. https://doi.org/10.1007/s00408-024-00702-5

Vancouver

Wang Y, Fei J, Xu J, Cheng ZY, Ma YC, Wu JH, et al. Associations of the Serum KL-6 with Severity and Prognosis in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Lung. 2024;202(3):245-255. doi:10.1007/s00408-024-00702-5

BibTeX
@article{Wang2024,
  author = {Wang, Yu and Fei, Jun and Xu, Juan and Cheng, Zhen-Yu and Ma, Yi-Cheng and Wu, Ju-Hong and Yang, Jin and Zhao, Hui and Fu, Lin},
  title = {Associations of the Serum KL-6 with Severity and Prognosis in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease},
  journal = {Lung},
  year = {2024},
  volume = {202},
  number = {3},
  pages = {245--255},
  doi = {10.1007/s00408-024-00702-5}
}
Kostenlos starten →